Andrey Myketey - Advarra | LinkedIn (2024)

Activity

• After an amazing week at #SAPSapphire I was honored to represent #SAPNS2 at the UN to discuss security and innovation.

  

  After an amazing week at #SAPSapphire I was honored to represent #SAPNS2 at the UN to discuss security and innovation.

  Liked by Andrey Myketey

• 30th birthday for #PCMG gala dinner was an absolute blast! Thanks to those who organised the evening we had a great time, venue was spectacular…

  

  30th birthday for #PCMG gala dinner was an absolute blast! Thanks to those who organised the evening we had a great time, venue was spectacular…

  Liked by Andrey Myketey

• If your oncology trial needs IBC review, consider this: In a case study of 52 consecutive IBC submissions for NCI-designated Cancer Centers, Advarra…

  

  If your oncology trial needs IBC review, consider this: In a case study of 52 consecutive IBC submissions for NCI-designated Cancer Centers, Advarra…

  Liked by Andrey Myketey

Join now to see all activity

• Welcome ASCO attendees to sunshiny Chicago! Excited to support Lurie Comprehensive Cancer Center, Northwestern Medicine, and Cancer Survivors with my…

  

  Welcome ASCO attendees to sunshiny Chicago! Excited to support Lurie Comprehensive Cancer Center, Northwestern Medicine, and Cancer Survivors with my…

  Liked by Andrey Myketey

• Advarra's IRB can review your new #oncology protocol in 4-5 days – plus our IRB roster has the kind of expertise leading #cancer centers expect…

  

  Advarra's IRB can review your new #oncology protocol in 4-5 days – plus our IRB roster has the kind of expertise leading #cancer centers expect…

  Liked by Andrey Myketey

• Cancer research is complicated. Advarra’s Longboat clinical research experience technology guides study teams, sites, and patients through every…

  

  Cancer research is complicated. Advarra’s Longboat clinical research experience technology guides study teams, sites, and patients through every…

  Liked by Andrey Myketey

• Gene therapy is "having its moment," but in research face ethical and safety issues, regulatory hurdles, logistical challenges, and steep costs…

  

  Gene therapy is "having its moment," but in research face ethical and safety issues, regulatory hurdles, logistical challenges, and steep costs…

  Liked by Andrey Myketey

• Advarra has worked with every top oncology pharma sponsor and supports every NCI-designated Cancer Center. When you think oncology research, think…

  

  Advarra has worked with every top oncology pharma sponsor and supports every NCI-designated Cancer Center. When you think oncology research, think…

  Liked by Andrey Myketey

• Excited to announce our partnership with NIH as the NIAID sIRB. Find out why the agency selected Advarra and what it means for #clinicaltrials in…

  

  Excited to announce our partnership with NIH as the NIAID sIRB. Find out why the agency selected Advarra and what it means for #clinicaltrials in…

  Liked by Andrey Myketey

• Happy to share my first blog published for Advarra! Let me know what you think!

  

  Happy to share my first blog published for Advarra! Let me know what you think!

  Liked by Andrey Myketey

• Thrilled to join the superb team at Mirror Biologics! We are striving to revolutionize immuno-oncology with AlloStim®, a non-genetically engineered…

  

  Thrilled to join the superb team at Mirror Biologics! We are striving to revolutionize immuno-oncology with AlloStim®, a non-genetically engineered…

  Liked by Andrey Myketey

• Reduce protocol deviations and increase engagement from sites and patients to boost quality in your clinical trials..

  

  Reduce protocol deviations and increase engagement from sites and patients to boost quality in your clinical trials..

  Liked by Andrey Myketey

• Stay ahead of the curve with Advarra's breakdown of FDA’s 2024 DMC draft guidance and how it impacts sponsors and CROs. Update your planning approach…

  

  Stay ahead of the curve with Advarra's breakdown of FDA’s 2024 DMC draft guidance and how it impacts sponsors and CROs. Update your planning approach…

  Liked by Andrey Myketey

• Clinical Trials Day 2024 is coming up in a few days!We're celebrating the contributions of these #TrailblazersAmongUs:Susan P. Landis, ACRP -…

  

  Clinical Trials Day 2024 is coming up in a few days!We're celebrating the contributions of these #TrailblazersAmongUs:Susan P. Landis, ACRP -…

  Liked by Andrey Myketey

• My Advarra colleague, Frank Conte, recently shared his expert views on the proposed single IRB mandate by the #FDA and its broad implications for…

  

  My Advarra colleague, Frank Conte, recently shared his expert views on the proposed single IRB mandate by the #FDA and its broad implications for…

  Liked by Andrey Myketey

• Oscar Segurado, MD, PhD, Chief Medical Officer at ASC Therapeutics illuminated the stage last night at the 20th BioPharma Clinical Trials Nexus…

  

  Oscar Segurado, MD, PhD, Chief Medical Officer at ASC Therapeutics illuminated the stage last night at the 20th BioPharma Clinical Trials Nexus…

  Liked by Andrey Myketey

• What does FDA guidance say about long-term follow up for cell and gene therapies research? Find out this and other valuable insights in Advarra's new…

  

  What does FDA guidance say about long-term follow up for cell and gene therapies research? Find out this and other valuable insights in Advarra's new…

  Liked by Andrey Myketey

• Click to watch and learn more about us as a trusted CDMO partner. We offer industry-leading pharma services through an integrated global network of…

  

  Click to watch and learn more about us as a trusted CDMO partner. We offer industry-leading pharma services through an integrated global network of…

  Liked by Andrey Myketey